Reference intervals of serum lipids in the second and third trimesters of pregnancy in a Caucasian cohort: the LIFE Child study.
Caucasian cohort
LIFE Child
Pregnancy
Reference data
Serum lipids
Journal
Archives of gynecology and obstetrics
ISSN: 1432-0711
Titre abrégé: Arch Gynecol Obstet
Pays: Germany
ID NLM: 8710213
Informations de publication
Date de publication:
12 2019
12 2019
Historique:
received:
06
05
2019
accepted:
15
10
2019
pubmed:
2
11
2019
medline:
23
6
2020
entrez:
1
11
2019
Statut:
ppublish
Résumé
The study aimed to establish reference intervals for serum lipids and apolipoproteins in pregnant women depending on trimester and parity, and to investigate the influence of various factors on lipid and apolipoprotein concentrations. A total of 748 pregnant women (n = 683 in the second trimester, n = 676 in the third trimester) were included in the study and reference intervals for total cholesterol (TC), HDL, LDL, triglycerides (TG), apoA1 and apoB were determined as empirical quantiles. The measurement of serum lipids was performed using a validated specific homozygous enzymatic color test. Hierarchical models were used to investigate hypothesized relations. Except for apoA1, all serum lipids levels showed a significant change from the second to the third trimester. This increase was most pronounced for TGs. Especially in the third trimester, the concentrations of serum lipids exceeded the currently accepted reference values for non-pregnant women by a factor of 2.5. Reference intervals of serum lipids at the second and third trimesters in healthy pregnant women were as following: TC 4.45-8.99 and 4.83-9.71 mmol/l, HDL 1.33-3.06 and 1.16-3.13 mmol/l, LDL 2.14-6.11 and 2.35-6.98 mmol/l, TG 0.92-3.0 and 1.37-4.76 mmol/l as well as apoB 0.69-1.93 and 0.85-2.21 g/l. Parity and nutrient intake were not significantly associated with changes in lipid concentration. Prematurity was associated with a significant decrease in TC and TG levels. Detailed reference values for serum lipids and apolipoproteins in pregnancy are now available for a Caucasian cohort. Further, long-term studies are still needed to assess the effect of the extensive concentration changes of serum lipids in pregnancy and their atherogenic risk definitively.
Sections du résumé
BACKGROUND
The study aimed to establish reference intervals for serum lipids and apolipoproteins in pregnant women depending on trimester and parity, and to investigate the influence of various factors on lipid and apolipoprotein concentrations.
MATERIALS AND METHODS
A total of 748 pregnant women (n = 683 in the second trimester, n = 676 in the third trimester) were included in the study and reference intervals for total cholesterol (TC), HDL, LDL, triglycerides (TG), apoA1 and apoB were determined as empirical quantiles. The measurement of serum lipids was performed using a validated specific homozygous enzymatic color test. Hierarchical models were used to investigate hypothesized relations.
RESULTS
Except for apoA1, all serum lipids levels showed a significant change from the second to the third trimester. This increase was most pronounced for TGs. Especially in the third trimester, the concentrations of serum lipids exceeded the currently accepted reference values for non-pregnant women by a factor of 2.5. Reference intervals of serum lipids at the second and third trimesters in healthy pregnant women were as following: TC 4.45-8.99 and 4.83-9.71 mmol/l, HDL 1.33-3.06 and 1.16-3.13 mmol/l, LDL 2.14-6.11 and 2.35-6.98 mmol/l, TG 0.92-3.0 and 1.37-4.76 mmol/l as well as apoB 0.69-1.93 and 0.85-2.21 g/l. Parity and nutrient intake were not significantly associated with changes in lipid concentration. Prematurity was associated with a significant decrease in TC and TG levels.
CONCLUSION
Detailed reference values for serum lipids and apolipoproteins in pregnancy are now available for a Caucasian cohort. Further, long-term studies are still needed to assess the effect of the extensive concentration changes of serum lipids in pregnancy and their atherogenic risk definitively.
Identifiants
pubmed: 31667609
doi: 10.1007/s00404-019-05342-2
pii: 10.1007/s00404-019-05342-2
doi:
Substances chimiques
APOA1 protein, human
0
APOB protein, human
0
Apolipoprotein A-I
0
Apolipoprotein B-100
0
Apolipoproteins
0
Lipids
0
Triglycerides
0
Cholesterol
97C5T2UQ7J
Banques de données
ClinicalTrials.gov
['NCT02550236']
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM